Skip Navigation


Nucleic Acids Research Advance Access originally published online on September 18, 2006
Nucleic Acids Research 2006 34(17):4976-4986; doi:10.1093/nar/gkl660
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (2968K) Freely available
Right arrow Screen PDF (845K) Freely available
Right arrowOA All Versions of this Article:
34/17/4976    most recent
gkl660v3
gkl660v2
gkl660v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Mangs, A. H.
Right arrow Articles by Morris, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mangs, A. H.
Right arrow Articles by Morris, B. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2006, Vol. 34, No. 17 4976-4986
© 2006 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Molecular Biology

XE7: A novel splicing factor that interacts with ASF/SF2 and ZNF265

A. Helena Mangs, Helen J.L. Speirs, Christine Goy, David J. Adams, M. Andrea Markus and Brian J. Morris*

Basic & Clinical Genomics Laboratory, School of Medical Sciences and Bosch Institute, The University of Sydney NSW 2006, Australia

*To whom correspondence should be addressed. Tel: +61-2-93513688; Fax: +61-2-93512227; Email: brianm{at}medsci.usyd.edu.au

Received May 3, 2006. Revised August 18, 2006. Accepted August 28, 2006.

Pre-mRNA splicing is performed by the spliceosome. SR proteins in this macromolecular complex are essential for both constitutive and alternative splicing. By using the SR-related protein ZNF265 as bait in a yeast two-hybrid screen, we pulled out the uncharacterized human protein XE7, which is encoded by a pseudoautosomal gene. XE7 had been identified in a large-scale proteomic analysis of the human spliceosome. It consists of two different isoforms produced by alternative splicing. The arginine/serine (RS)-rich region in the larger of these suggests a role in mRNA processing. Herein we show for the first time that XE7 is an alternative splicing regulator. XE7 interacts with ZNF265, as well as with the essential SR protein ASF/SF2. The RS-rich region of XE7 dictates both interactions. We show that XE7 localizes in the nucleus of human cells, where it colocalizes with both ZNF265 and ASF/SF2, as well as with other SR proteins, in speckles. We also demonstrate that XE7 influences alternative splice site selection of pre-mRNAs from CD44, Tra2-ß1 and SRp20 minigenes. We have thus shown that the spliceosomal component XE7 resembles an SR-related splicing protein, and can influence alternative splicing.

Present addresses: Helen J.L. Speirs, Clive & Vera Ramaciotti Centre for Gene Function Analysis, School of Biotechnology & Biomolecular Sciences, University of New South Wales, Sydney NSW 2052, Australia

David J. Adams, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambs CB10 1SA, UK

The history dates have been corrected.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum Mol GenetHome page
A. Suraweera, Y. Lim, R. Woods, G. W. Birrell, T. Nasim, O. J. Becherel, and M. F. Lavin
Functional role for senataxin, defective in ataxia oculomotor apraxia type 2, in transcriptional regulation
Hum. Mol. Genet., September 15, 2009; 18(18): 3384 - 3396.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.